A founder-led, cash-gushing R&D tax “tollbridge” with dominant German share and global runway—yet priced like a broken IPO despite 60% growth and 60% margins.
Overview
innoscripta SE is a Munich-based, highly specialized technology and digitized consultancy focused on R&D tax compliance and project portfolio management. Its proprietary cloud SaaS platform, Clusterix, automates the complex, documentation-heavy process of identifying eligible R&D projects, compiling audit-proof evidence, and submitting claims to tax authorities. The company’s monetization is unusual: rather than standard subscriptions, it primarily charges a ~20% success fee on the R&D tax refund actually approved and paid to the client, aligning incentives and reducing sales friction but tying revenue to R&D spend and government refund mechanics. Clusterix is built around OECD Frascati Manual criteria and integrates time tracking, payroll history, employee management, and PPM workflows to generate compliant documentation that reduces audit risk. The firm is scaling rapidly—>2,500 clients across R&D-intensive sectors and ~800 new clients added in FY2025—with particularly strong dominance in Germany (estimated >27% share of its defined segment; ~3,200 applications processed). To mitigate volatility from success-fee dependence, innoscripta is developing a separate PPM SaaS offering to introduce recurring subscription revenue and broaden its product beyond tax claims.